Literature DB >> 1416836

Deleterious effect of trimethoprim-sulfamethoxazole in Mediterranean spotted fever.

R Ruiz Beltrán, J I Herrero Herrero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1416836      PMCID： PMC190344          DOI： 10.1128/AAC.36.6.1342

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

1.  Treatment of Rocky Mountain spotted fever with antibiotics.

Authors:  G T HARRELL
Journal:  Ann N Y Acad Sci       Date:  1952-12-30       Impact factor: 5.691

Review 2.  Antimicrobial therapy of rickettsial diseases.

Authors:  D Raoult; M Drancourt
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

3.  [Mediterranean boutonneuse fever (apropos of 40 recent cases in Marseilles].

Authors:  A Bourgeade; M J Jean-Pastor; D Raoult
Journal:  Bull Soc Pathol Exot Filiales       Date:  1979 Jul-Aug

4.  [Mediterranean boutonneuse fever. Trimethoprim-sulfamethoxazole, treatment of choice].

Authors:  F Marcos Sánchez; J L Turabian Fernández; J L Moreiras Jiménez; P Gorgolas Hernández; A Durán Pérez-Navarro
Journal:  Med Clin (Barc)       Date:  1983-07-16       Impact factor: 1.725

5.  Antibiotic susceptibility of rickettsia and treatment of rickettsioses.

Authors:  D Raoult
Journal:  Eur J Epidemiol       Date:  1989-12       Impact factor: 8.082
  5 in total
  8 in total

Review 1.  Host, pathogen and treatment-related prognostic factors in rickettsioses.

Authors:  E Botelho-Nevers; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-26       Impact factor: 3.267

Review 2.  Tick-borne infections in children: epidemiology, clinical manifestations, and optimal management strategies.

Authors:  Steven C Buckingham
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 3.  Tick-borne rickettsioses around the world: emerging diseases challenging old concepts.

Authors:  Philippe Parola; Christopher D Paddock; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

4.  In vitro susceptibilities of 27 rickettsiae to 13 antimicrobials.

Authors:  J M Rolain; M Maurin; G Vestris; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

5.  Fatal spotted fever rickettsiosis, Kenya.

Authors:  Jeremiah S Rutherford; Kevin R Macaluso; Nathaniel Smith; Sherif R Zaki; Christopher D Paddock; Jon Davis; Norman Peterson; Abdu F Azad; Ronald Rosenberg
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

6.  Acute spotted fever rickettsiosis among febrile patients, Cameroon.

Authors:  Lucy M Ndip; Donald H Bouyer; Amelia P A Travassos Da Rosa; V P K Titanji; Robert B Tesh; David H Walker
Journal:  Emerg Infect Dis       Date:  2004-03       Impact factor: 6.883

7.  Assessment of Risk Factors and Outcomes of Severe Ehrlichiosis Infection.

Authors:  Kevin Kuriakose; April C Pettit; Jonathan Schmitz; Abelardo Moncayo; Karen C Bloch
Journal:  JAMA Netw Open       Date:  2020-11-02

Review 8.  Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature.

Authors:  Andrea De Vito; Nicholas Geremia; Sabrina Maria Mameli; Vito Fiore; Pier Andrea Serra; Gaia Rocchitta; Susanna Nuvoli; Angela Spanu; Renato Lobrano; Antonio Cossu; Sergio Babudieri; Giordano Madeddu
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-09-01       Impact factor: 2.576
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.